NASDAQ : CUVL
Clinuvel Pharmaceuticals Limited — Financial statements
Australia
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Clinuvel Pharmaceuticals Limited (CUVL) reported revenue of 94.02M AUD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 94.02M | 94.02M | 95.02M | 81.22M | 72.18M | 60.00M |
| Other Revenue | 6.96M | 6.14M | 5.72M | |||
| Revenue | 94.02M | 94.02M | 95.02M | 88.18M | 78.32M | 65.72M |
| Cost of Revenue | 15.81M | 15.81M | 14.81M | 7.73M | 7.52M | 9.25M |
| Gross Profit | 78.21M | 78.21M | 80.20M | 80.45M | 70.80M | 56.47M |
| Selling, General & Admin | 19.59M | 19.59M | 18.23M | 22.84M | 15.65M | 13.03M |
| Research & Development | 18.09M | 18.09M | 20.70M | 2.35M | 1.27M | 1.23M |
| Other Operating Expenses | -562.94K | -23.82K | -216.84K | |||
| Operating Expenses | 37.68M | 37.68M | 38.93M | 31.88M | 26.67M | 20.92M |
| Operating Income | 40.53M | 40.53M | 41.27M | 48.57M | 44.13M | 35.55M |
| Interest Expense | -4.45M | -3.19M | -2.27M | |||
| Interest & Investment Income | 10.45M | 10.45M | 9.43M | 7.32M | 3.91M | 444.07K |
| Currency Exchange Gain (Loss) | -3.96M | -3.96M | 827.73K | -760.38K | 739.26K | 604.32K |
| Other Non Operating Income (Expenses) | 644.89K | 644.89K | 24.18K | |||
| EBT Excluding Unusual Items | 47.66M | 47.66M | 51.55M | 50.68M | 45.58M | 34.32M |
| Pretax Income | 47.66M | 47.66M | 51.55M | 50.68M | 45.58M | 34.32M |
| Income Tax Expense | 13.74M | 13.74M | 15.38M | 15.04M | 14.97M | 13.44M |
| Earnings From Continuing Operations | 33.92M | 33.92M | 36.17M | 35.64M | 30.60M | 20.88M |
| Net Income | 33.92M | 33.92M | 36.17M | 35.64M | 30.60M | 20.88M |
| Net Income to Common | 33.92M | 33.92M | 36.17M | 35.64M | 30.60M | 20.88M |
| Shares Outstanding (Basic) | 50.01M | 50.01M | 50.08M | 49.83M | 49.41M | 49.41M |
| Shares Outstanding (Diluted) | 50.75M | 50.75M | 50.38M | 51.03M | 51.82M | 51.78M |
| EPS (Basic) | 0.68 | 0.68 | 0.72 | 0.72 | 0.62 | 0.42 |
| EPS (Diluted) | 0.67 | 0.67 | 0.72 | 0.70 | 0.59 | 0.40 |
| Free Cash Flow | 35.31M | 35.31M | 40.80M | 31.48M | 35.88M | 39.44M |
| Free Cash Flow Per Share | 0.70 | 0.70 | 0.81 | 0.62 | 0.69 | 0.76 |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| Gross Margin | 83.18% | 83.18% | 84.41% | 91.23% | 90.40% | 85.92% |
| Operating Margin | 43.11% | 43.11% | 43.43% | 55.08% | 56.34% | 54.09% |
| Profit Margin | 36.07% | 36.07% | 38.07% | 40.41% | 39.08% | 31.77% |
| Free Cash Flow Margin | 37.55% | 37.55% | 42.94% | 35.70% | 45.82% | 60.01% |
| EBITDA | 41.11M | 41.11M | 42.06M | 49.32M | 44.52M | 35.97M |
| EBITDA Margin | 43.72% | 43.72% | 44.26% | 55.93% | 56.85% | 54.74% |
| D&A For EBITDA | 576.59K | 576.59K | 786.66K | 753.18K | 397.26K | 426.70K |
| EBIT | 40.53M | 40.53M | 41.27M | 48.57M | 44.13M | 35.55M |
| EBIT Margin | 43.11% | 43.11% | 43.43% | 55.08% | 56.34% | 54.09% |
| Effective Tax Rate | 28.84% | 28.84% | 29.83% | 29.68% | 32.85% | 39.17% |
| Revenue as Reported | 95.31M | 82.99M |
Balance sheet
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 21.39M | 21.39M | 28.02M | 35.20M | 31.89M | 121.51M |
| Short-Term Investments | 230.66M | 230.66M | 196.09M | 148.67M | 124.92M | |
| Cash & Short-Term Investments | 252.06M | 252.06M | 224.11M | 183.87M | 156.81M | 121.51M |
| Accounts Receivable | 18.72M | 18.72M | 24.17M | 25.01M | 20.64M | 15.90M |
| Other Receivables | 4.74M | 4.74M | 3.30M | 1.23M | 1.57M | 303.92K |
| Receivables | 23.45M | 23.45M | 27.46M | 26.24M | 22.21M | 16.20M |
| Inventory | 6.88M | 6.88M | 8.82M | 10.63M | 9.52M | 1.83M |
| Prepaid Expenses | 1.04M | |||||
| Other Current Assets | 2.24M | 2.24M | 2.58M | 1.33M | 1.07M | |
| Total Current Assets | 284.63M | 284.63M | 262.97M | 222.06M | 189.62M | 140.58M |
| Property, Plant & Equipment | 9.25M | 9.25M | 7.13M | 7.72M | 2.85M | 2.70M |
| Long-Term Investments | 217.61K | 217.61K | 213.34K | 134.21K | ||
| Goodwill | 185.03K | |||||
| Other Intangible Assets | 185.03K | 185.03K | 185.03K | 185.03K | 185.03K | |
| Long-Term Deferred Tax Assets | 812.26K | 812.26K | 1.26M | 1.02M | 1.06M | 481.60K |
| Total Assets | 295.09M | 295.09M | 271.75M | 231.12M | 193.71M | 143.95M |
| Accounts Payable | 1.28M | 1.28M | 2.55M | 2.35M | 2.79M | 259.20K |
| Accrued Expenses | 2.87M | 2.87M | 2.29M | 1.88M | 1.45M | 2.86M |
| Current Portion of Leases | 388.62K | 388.62K | 431.18K | 369.86K | 300.84K | 315.07K |
| Current Income Taxes Payable | 6.71M | 6.71M | 14.55M | 15.85M | 16.09M | 7.28M |
| Other Current Liabilities | 7.97M | 7.97M | 7.39M | 4.76M | 4.86M | 3.02M |
| Total Current Liabilities | 19.22M | 19.22M | 27.21M | 25.21M | 25.49M | 13.73M |
| Long-Term Leases | 1.55M | 1.55M | 97.34K | 509.92K | 699.02K | 941.46K |
| Pension & Post-Retirement Benefits | 120.56K | 120.56K | 127.79K | 84.72K | 56.57K | 31.64K |
| Long-Term Deferred Tax Liabilities | 1.19M | 1.19M | 3.42M | 2.23M | 2.76M | 3.62M |
| Other Long-Term Liabilities | 135.80K | 135.80K | 85.47K | 79.24K | 74.59K | 69.91K |
| Total Liabilities | 22.21M | 22.21M | 30.94M | 28.11M | 29.08M | 18.39M |
| Common Stock | 172.31M | 172.31M | 169.28M | 168.80M | 151.85M | 151.85M |
| Retained Earnings | 95.04M | 95.04M | 63.63M | 29.96M | -9.77M | -38.40M |
| Comprehensive Income & Other | 5.53M | 5.53M | 7.90M | 4.25M | 22.56M | 12.11M |
| Total Common Equity | 272.88M | 272.88M | 240.81M | 203.01M | 164.63M | 125.56M |
| Shareholders' Equity | 272.88M | 272.88M | 240.81M | 203.01M | 164.63M | 125.56M |
| Total Liabilities & Equity | 295.09M | 295.09M | 271.75M | 231.12M | 193.71M | 143.95M |
| Total Debt | 1.94M | 1.94M | 528.53K | 879.78K | 999.87K | 1.26M |
| Net Cash (Debt) | 250.12M | 250.12M | 223.58M | 182.99M | 155.81M | 120.25M |
| Net Cash Per Share | 4.93 | 4.93 | 4.44 | 3.59 | 3.01 | 2.32 |
| Filing Date Shares Outstanding | 50.43M | 50.43M | 50.12M | 50.08M | 49.41M | 49.41M |
| Total Common Shares Outstanding | 50.43M | 50.43M | 50.12M | 50.08M | 49.41M | 49.41M |
| Working Capital | 265.41M | 265.41M | 235.76M | 196.85M | 164.12M | 126.85M |
| Book Value Per Share | 5.41 | 5.41 | 4.80 | 4.05 | 3.33 | 2.54 |
| Tangible Book Value | 272.70M | 272.70M | 240.62M | 202.83M | 164.45M | 125.37M |
| Tangible Book Value Per Share | 5.41 | 5.41 | 4.80 | 4.05 | 3.33 | 2.54 |
| Land | 5.02M | 5.02M | 5.02M | 4.97M | ||
| Machinery | 2.01M | 2.01M | 2.19M | 1.94M | 1.53M | 1.33M |
| Construction In Progress | 1.24M | 1.24M | ||||
| Leasehold Improvements | 1.99M | 1.99M | 1.99M | 1.99M | 1.89M | 1.25M |
Cash flow statement
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | 33.92M | 33.92M | 36.17M | 35.64M | 30.60M | 20.88M |
| Depreciation & Amortization | 985.47K | 985.47K | 1.15M | 1.09M | 740.90K | 716.59K |
| Loss (Gain) From Sale of Assets | 57.24K | 57.24K | 27.38K | |||
| Stock-Based Compensation | 2.34M | 2.34M | 2.00M | 6.11M | 8.99M | 6.12M |
| Provision & Write-off of Bad Debts | -152.96K | -152.96K | ||||
| Other Operating Activities | 3.03M | 3.03M | -422.56K | 669.20K | -205.69K | 173.22K |
| Change in Accounts Receivable | 4.16M | 4.16M | -1.22M | -4.02M | -6.01M | -113.41K |
| Change in Inventory | 1.94M | 1.94M | 1.81M | -1.11M | -7.69M | 1.35M |
| Change in Accounts Payable | -698.72K | -698.72K | 2.84M | -648.32K | 4.51M | -1.56M |
| Change in Income Taxes | -7.83M | -7.83M | -1.30M | -242.79K | 8.81M | 7.18M |
| Change in Other Net Operating Assets | 958.20K | 958.20K | -873.92K | 70.06K | -1.41M | -971.57K |
| Operating Cash Flow | 36.91M | 36.91M | 41.10M | 37.05M | 36.91M | 39.87M |
| Capital Expenditures | -1.60M | -1.60M | -298.57K | -5.58M | -1.03M | -434.44K |
| Investment in Securities | -37.52M | -37.52M | -47.42M | -23.46M | -30.82M | |
| Investing Cash Flow | -39.12M | -39.12M | -47.72M | -29.03M | -31.85M | -434.44K |
| Long-Term Debt Repaid | -238.64K | -238.64K | -182.70K | -347.34K | -263.72K | -268.49K |
| Lease Payments | -238.64K | -238.64K | -182.70K | -347.34K | -263.72K | -268.49K |
| Net Debt Issued (Repaid) | -238.64K | -238.64K | -182.70K | -347.34K | -263.72K | -268.49K |
| Issuance of Common Stock | 563.97K | 563.97K | 189.00K | 4.16M | ||
| Repurchase of Common Stock | -563.97K | -563.97K | -440.91K | -4.91M | ||
| Common Dividends Paid | -2.51M | -2.51M | -2.50M | -2.47M | -1.98M | -1.24M |
| Other Financing Activities | -10.37K | -10.37K | ||||
| Financing Cash Flow | -2.75M | -2.75M | -2.94M | -3.57M | -2.24M | -1.50M |
| Foreign Exchange Rate Adjustments | -1.67M | -1.67M | 2.38M | -1.14M | 1.66M | 884.21K |
| Net Cash Flow | -6.63M | -6.63M | -7.18M | 3.31M | 4.48M | 38.82M |
| Free Cash Flow | 35.31M | 35.31M | 40.80M | 31.48M | 35.88M | 39.44M |
| Free Cash Flow Margin | 37.55% | 37.55% | 42.94% | 35.70% | 45.82% | 60.01% |
| Free Cash Flow Per Share | 0.70 | 0.70 | 0.81 | 0.62 | 0.69 | 0.76 |
| Levered Free Cash Flow | 25.39M | 25.39M | 29.91M | 23.45M | 32.33M | 33.25M |
| Unlevered Free Cash Flow | 25.39M | 25.39M | 29.91M | 26.23M | 34.33M | 34.67M |
| Free Cash Flow After Leases | 35.07M | 35.07M | 40.61M | 31.13M | 35.62M | 39.17M |
| Cash Income Tax Paid | 23.36M | 23.36M | 15.73M | 15.65M | 7.74M | |
| Change in Working Capital | -3.26M | -3.26M | 2.20M | -6.44M | -3.22M | 11.96M |
Ratios
Fiscal year July - June; amounts in AUD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 249.47M | 358.63M | 341.10M | 513.59M | 587.99M | 505.54M |
| Enterprise Value | 73.96M | 197.66M | 211.62M | 397.91M | 495.10M | 438.14M |
| Last Close Price | 4.91 | 7.27 | 6.75 | 9.69 | 11.81 | 10.11 |
| PE Ratio | 10.53 | 15.28 | 14.38 | 21.60 | 28.87 | 35.14 |
| PS Ratio | 3.84 | 5.51 | 5.48 | 8.73 | 11.28 | 11.16 |
| PB Ratio | 1.32 | 1.90 | 2.16 | 3.79 | 5.37 | 5.84 |
| P/TBV Ratio | 1.32 | 1.90 | 2.16 | 3.79 | 5.37 | 5.85 |
| P/FCF Ratio | 10.12 | 14.68 | 12.75 | 24.45 | 24.62 | 18.61 |
| P/OCF Ratio | 9.68 | 14.04 | 12.66 | 20.77 | 23.93 | 18.40 |
| EV/Sales Ratio | 1.14 | 3.04 | 3.40 | 6.76 | 9.50 | 9.68 |
| EV/EBITDA Ratio | 2.60 | 6.95 | 7.67 | 12.09 | 16.71 | 17.68 |
| EV/EBIT Ratio | 2.64 | 7.05 | 7.82 | 12.28 | 16.86 | 17.89 |
| EV/FCF Ratio | 3.00 | 8.09 | 7.91 | 18.95 | 20.73 | 16.12 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
| Debt / EBITDA Ratio | 0.05 | 0.05 | 0.01 | 0.02 | 0.02 | 0.03 |
| Debt / FCF Ratio | 0.06 | 0.06 | 0.01 | 0.03 | 0.03 | 0.03 |
| Net Debt / Equity Ratio | -0.92 | -0.92 | -0.93 | -0.90 | -0.95 | -0.96 |
| Net Debt / EBITDA Ratio | -6.08 | -6.08 | -5.32 | -3.71 | -3.50 | -3.34 |
| Net Debt / FCF Ratio | -7.08 | -7.08 | -5.48 | -5.81 | -4.34 | -3.05 |
| Asset Turnover | 0.33 | 0.33 | 0.38 | 0.41 | 0.46 | 0.52 |
| Inventory Turnover | 2.01 | 2.01 | 1.52 | 0.77 | 1.32 | 3.69 |
| Quick Ratio | 14.34 | 14.34 | 9.24 | 8.33 | 7.02 | 10.03 |
| Current Ratio | 14.81 | 14.81 | 9.66 | 8.81 | 7.44 | 10.24 |
| Return on Equity (ROE) | 13.21% | 13.21% | 16.30% | 19.39% | 21.09% | 18.62% |
| Return on Assets (ROA) | 8.94% | 8.94% | 10.26% | 14.29% | 16.34% | 17.60% |
| Return on Invested Capital (ROIC) | 126.71% | 144.24% | 155.46% | 236.84% | 336.03% | |
| Return on Capital Employed (ROCE) | 14.70% | 14.70% | 16.90% | 23.60% | 26.20% | 27.30% |
| Earnings Yield | 9.50% | 6.54% | 6.95% | 4.63% | 3.46% | 2.84% |
| FCF Yield | 9.88% | 6.81% | 7.84% | 4.09% | 4.06% | 5.38% |
| Dividend Yield | 0.58% | 0.49% | 0.48% | 0.33% | 0.28% | 0.27% |
| Payout Ratio | 6.04% | 7.39% | 6.92% | 6.93% | 6.46% | 5.92% |
| Buyback Yield / Dilution | -0.73% | -0.73% | 1.27% | 1.52% | -0.08% | -1.26% |
| Total Shareholder Return | -0.15% | -0.24% | 1.75% | 1.85% | 0.20% | -0.99% |